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The 2013 Muslim Hajj pilgrimage was completed in October.
Thankfully there have been, as of yet, no conﬁrmed cases of
Hajj-associated Middle East Respiratory Syndrome Coronavi-
rus (MERS-CoV) in Saudi Arabia or abroad. Screening PCR (E
gene) for the virus was positive in three samples from a
61-year-old woman who returned to Spain from the 2013 Hajj
pilgrimage on 1 November and one of her contacts who was
accompanying her on the Hajj journey who developed
symptoms on the same day and was suspected to have
acquired the infection from the ﬁrst case [1]. The ﬁrst patient,
who had no pre-existing medical condition, attended Hajj
during October in Saudi Arabia. She became symptomatic
3 days before departure and attended a hospital in Makkah
where pneumonia was conﬁrmed by chest X-ray. In-ﬂight to
Spain she needed oxygen and was hospitalized on arrival in
Madrid. However, sequencing for MERS-CoV has, to date,
been unsuccessful and deﬁnitive conﬁrmatory tests were
negative [1]. If positive, this could be the ﬁrst European case of
post-Hajj-associated MERS-CoV with a second case among
very close contacts.
In addition, multiple media reports about cases have related
to Hajj, including one suspected MERS-CoV death in Egypt that
was conﬁrmed negative by testing by the Egyptian health
authority, and an Omani man who died from conﬁrmed
MERS-CoV infection following presumed contact with a
son-in-law who had returned from Hajj (although the returning
pilgrim was negative on testing, so this is unlikely to be a
Hajj-associated case). Two additional case reports from India
appear to be false and a product of media hype [2,3]. Indeed,
many of these cases are likely to be ﬂu [4].
These reports raise several issues regarding returning
pilgrims in Europe and elsewhere, including the importance of
high-quality post-Hajj surveillance with rapid reliable testing.
In October 2013, about 2 million pilgrims from all parts of
the world attended Hajj pilgrimage in Saudi Arabia. Almost
all left Saudi Arabia by the end of November. As of 1
December 2013, 160 conﬁrmed MERS cases have been
reported worldwide, of whom 68 (42.5%) have died (Fig. 1)
[5]. Only nine cases (not including these Spanish cases) have
been recorded outside the Middle East: three in Tunisia, of
which one was ‘imported’ (i.e. brought in from the Middle
East but not diagnosed in country of origin), and six in
Europe [5]. Although much about the virus remains uncer-
tain, compared with severe acute respiratory syndrome
(SARS), it appears to have a higher mortality rate (42%
versus 10%), human-to-human spread is much slower and it
causes especially severe disease in those with a pre-existing
medical illness [6].
In 2012, MERS-CoV was actively searched for among a
cohort of French pilgrims during the Hajj but no case was
found [7]. A syndromic survey among Australian pilgrims was
also conducted among Hajjis in 2012 and no probable case was
identiﬁed [8].
Intense crowding, shared accommodation and exposure to
environmental dust and pollutants provide the ecology for
transmission of respiratory infections among pilgrims; at least
one-third of them are elderly and/or have pre-existing
chronic medical conditions. High attack rates of respiratory
infections, including inﬂuenza, pertussis and tuberculosis, have
in the past been reported at Hajj and there has been
intercontinental spread of potentially air-borne infections, e.g.
the meningococcal W135 outbreaks in 2000 and 2001 [9,10].
Pilgrims are likely to have had direct or indirect contact
with animals harbouring MERS-CoV. Sacriﬁcing four-footed
animals, including a small proportion of camels, is part of the
Hajj rituals, and between 1 and 2 million animals are sacriﬁced
at designated abattoirs located within walking distance of
pilgrims’ tents (Fig. 2). Although ofﬁcial slaughtering is now
performed by proxy by professional abattoir workers, the
meat is consumed by pilgrims, many of whom also enjoy camel
rides or photographs during their stay in Makkah. In recent
studies, a very high prevalence of neutralizing antibodies
against MERS-CoV has been found in Arabian camels of the
Middle East and Egypt [11,12]. Also, a camel in Jeddah has been
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reported to have an active infection (i.e. PCR positive), whose
owner was also infected [13]. Bats have been suspected as a
possible source for the MERS-CoV with part of the genome
identiﬁed in a faecal sample from an Egyptian tomb bat
captured in the living vicinity of a patient from Bisha, Saudi
Arabia [14]. Human contact with fruit bat excreta/secretions,
by consuming unwashed fruits, especially dates which are a Hajj
delicacy, might increase the risk of MERS-CoV.
In most Muslim communities worldwide, it is a tradition for
friends and relatives to warmly welcome returned pilgrims,
who also meet and visit their friends and neighbours in the
mosques and community centres. This involves close contact,
particularly hugging. Those who are unwell are especially
looked after and visited more frequently. A recent report
suggests the possibility of transmission of MERS-CoV from
unrecognized asymptomatic or mild cases [15]. Also, in
countries that do not routinely test for MERS-CoV, unrecog-
nized cases might not be able to be linked deﬁnitively to Hajj
despite heightened post-Hajj surveillance.
Observational studies conducted during the SARS epidemic
of 2003 demonstrated the importance of hand washing in
healthcare workers. This was shown to be effective if
performed a minimum of 11 times daily and used with other
FIG. 1. Map of reported Middle East respiratory syndrome cases.
FIG. 2. Herd of camels at the Hajj site in Mina, Makkah.
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personal protective measures (e.g. facemasks, gowns and
goggles) while caring for the sick [16]. Hand hygiene, especially
after sneezing, yawning and cleaning the nose, is important, and
complements Muslims’ daily ablutions, which are performed at
least ﬁve times before prayers [17]. A recent survey
conducted among French pilgrims has shown that these
measures are acceptable to pilgrims [18]. As individuals with
co-morbidities are at particularly high risk of infection and
severe disease [6], protection of pilgrims and their households
is achieved by vaccination against inﬂuenza, pneumococcal
disease, measles and pertussis (if not already up to date), the
control of pre-existing diseases like bronchial asthma and
diabetes, and smoking cessation.
The French survey also showed that about 35% of pilgrims
were not aware of the MERS situation in Saudi Arabia [18], and
indicated the importance of awareness and educational
campaigns with the help of mass media. Misleading media
reports should be rapidly corrected. Healthcare workers who
look after the pilgrims also need education about the disease,
its prevention, diagnosis and reporting. Diagnostic tests should
be readily available to front-line medical staff. Any returned
Hajj pilgrim presenting with symptoms suggestive of respira-
tory infection, particularly pneumonia, should be suspected of
having MERS-CoV, and contact tracing of conﬁrmed cases is
essential.
Careful and systematic post-Hajj surveillance is required
with international cooperation from health systems, airlines
and airport authorities who should have a proper
understanding of its purpose. Targeted research to identify
the source(s) of MERS-CoV, modes of transmission,
therapeutic options, vaccine development and other pre-
ventive actions are all a priority. With respect to prevention,
we embarked on a large trial to assess the efﬁcacy of
facemasks against respiratory viruses including MERS-CoV
and inﬂuenza at this year’s Hajj and this will continue next
year. We hope the trial will determine if facemasks are
effective in preventing viral respiratory infection such as
MERS-CoV and inﬂuenza.
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